INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-827581056 scientists]( "Stability Screening For Colloidal Stability: Diffusion Interaction Parameter Thermal Shift Assay")
Stability Screening For Colloidal Stability: Diffusion Interaction Parameter Thermal Shift AssayColloidal stability is one of the most important properties to control due to the propensity for biopharmaceuticals to aggregate and the subsequent potential to severely affect the drug's efficacy and patient safety.
-
![GettyImages-178896317 scientist, lab]( "Why Cell Line Screening Is Crucial For Successful CDC Assay Development")
-
![GettyImages-547131922 research, regulatory, lab]( "Accelerated Tox Offerings: A Recipe For Streamlining IND Applications")
Accelerated Tox Offerings: A Recipe For Streamlining IND ApplicationsAccelerating the timeline to tox material can significantly enhance the drug development process, enabling faster IND submissions and providing crucial time savings for toxicology studies.
-
![Why Is Whole-Body PK Important]( "Early-Phase Whole-Body PK")
Early-Phase Whole-Body PKAccelerate your path to the clinic with Aliri’s cost-effective, label-free whole-body PK service — designed to deliver deeper insights, faster decisions, and better outcomes for your drug candidates.
-
Label-Free Whole-Body Pharmacokinetics4/21/2025
This approach enables tissue-level analysis, delivering insights into efficacy at the site of action, uncovering potential safety concerns, and supporting smarter clinical candidate selection.
-
Time: A Crucial Factor In Therapeutics Development4/21/2025
Accelerate your mRNA development and strengthen your response to emerging health threats with next-generation, cell-free DNA template solutions designed for speed, quality, and reliability.
-
Enabling mRNA Therapeutic Development Through Enhanced IVT Capping Efficiency4/16/2025
See how Codex HiCap RNA Polymerase supports the production of high-performance synthetic mRNA, paving the way for next-generation mRNA therapies.
-
Challenges In ADC Production - Consolidating Operations Under One Roof4/15/2025
Eurofins CDMO Alphora consolidates ADC development and manufacturing under one roof, streamlining processes, enhancing safety, and accelerating delivery of high-quality, clinically-ready antibody-drug conjugates.
DRUG DEVELOPMENT SOLUTIONS
-
![adarapharma2]( "Adare Pharma Solutions (APS) Orbis Overview")
Orbis provides innovative taste-making and controlled release solutions for oral and injectable pharmaceutical products.
-
![GettyImages-1304835356-virus-cells-outbreak-strain]( "Advancing Vaccines From Preclinical Development To Commercial Supply")
We are an established leader in advancing vaccines from preclinical development to commercial supply across multiple modalities.
-
![Chromatography GettyImages-1392302602]( "Drug Characterization And Release Testing Services")
Learn how leveraging the expertise and flexibility of a partner empowers you to ensure regulatory compliance from the outset, with thorough characterization starting at the earliest stages.
-
![GettyImages-2152418328-ADC-antibody-drug-conjugate-3d]( "Engineering Antibodies And Proteins")
Accurate protein engineering has become an essential step in the early discovery phase, minimizing the need for costly redesigns and process optimizations later in development.
-
Improve productivity and cell growth in fed-batch cultures by supplementing the cell culture medium to boost nutrients depleted during culture. HyClone™ Cell Boost™ 2 Supplement provides nutrients such as amino acids and glucose that are suitable for research and bioprocessing applications.
